Find clinical trials for hidradenitis suppurativa. Search for hidradenitis suppurativa clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 41
Active & Responsive
Participants with Mild to Moderate Hidradenitis Suppurativa Will Receive EVO101 a Topical Cream 0.1%
for
Hidradenitis Suppurativa (HS)
Location: Norfolk VA
Sponsor: Virginia Clinical Research, Inc.
Sex: All
Age: 18+
Code: NCT06645821
Early_phase1, Recruiting
Active & Responsive
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Location: San Francisco CA, Stanford CA, Aurora CO, Chicago IL,
Sponsor: Sonoma Biotherapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07123038
Recruiting
Active & Responsive
Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT06058520
Early_phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
for
Hidradenitis Suppurativa
Location: Troy MI
Sponsor: Pfizer
Sex: All
Age: 18 - 70+
Code: NCT07228390
Phase2, Recruiting
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Phoenix AZ, Fort Smith AR, North Little Rock AR,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06799000
Phase3, Recruiting
Clinical and Biological Characteristics of Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 13+
Code: NCT03967600
Recruiting
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Boston MA, Minneapolis MN, Saint Louis MO, New York NY,
Sponsor: Sonoma Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT06361836
Phase1, Recruiting
Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin